Newron Pharmaceuticals Spa. (NWRN.SW) Q1 2026 Earnings

24MarConfirmed
Q3 2024
Q2 2025
Q3 2025
Q1 2026
-0.61
-0.41
-0.2
0

Details

Expected EPS
-0.518182536704
Actual EPS
-0.610715132544
Surprise EPS
-0.09
Surprise Percent
+17.86%

Description

Newron Pharmaceuticals Spa. (NWRN.SW) has reported earnings of -0.610715132544 per share for Q1 2026.

0 Comments

Share your thoughts